Immune Cell Killing of Tumor Cells | Automatically Measure the Time Course with the IncuCyte® System

Video   Oct 06, 2016

 

Time-lapse movies acquired using IncuCyte® ZOOM live-cell analysis system showing a T cell sub population of PBMCs, activated with anti-CD3 antibody and IL-2, killing target SK-OV-3 tumor cells. Labeling of the SK-OV-3 cancer cells with the NucLight Red™ Live-Cell Labeling reagent enables direct counting of viable tumor cell numbers over-time. Addition of the IncuCyte™ Caspase 3/7 apoptosis reagent enables simultaneous detection of cells undergoing apoptosis (green fluorescence).

Assay concept:

● Target tumor cells are co-cultured with your immune cells of choice (e.g., T cells or human peripheral blood mononuclear cells; PBMCs).
● Tumor cell death is measured directly and in real-time by adding the mix-and-read IncuCyte™ Caspase 3/7 Reagent to your cultures.
● Tumor cell counts can be enabled by labeling target cells with NucLight™ Live-Cell Labeling Reagents
● Automated image analysis enables selective quantitation of tumor cell death.

Learn more at www.essenbio.com/immune-cell-killing

 
Company Information
 
 
 

Recommended Videos

Thaw, Plate, Incubate: Cryopreserved Hepatocyte Thawing and Plating Instructions

Video

This video guide provides step-by-step instructions on the proper way to thaw, plate, and incubate cryopreserved hepatocytes for optimal results.

WATCH NOW

Expansion Pathology

Video

By physically magnifying biological samples up to 100 times their original volume, researchers are able to image cells with much higher resolution using a conventional microscope.

WATCH NOW

Should You Pee on Jellyfish Stings?

Video

Filmed at San Francisco's Aquarium of the Bay, the latest Reactions episode explains the fearsome chemistry of jellyfish stings, and debunks this age-old beach myth.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE